Get the Stockscreener App
88.12
0.14%
0.07
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $88.12, with a volume of 3.92M.
It is up +0.14% in the last 24 hours and down -12.72% over the past month.
See More
Previous Close:
$88.05
Open:
$87.52
24h Volume:
3.92M
Relative Volume:
0.35
Market Cap:
$251.88B
Revenue:
$64.17B
Net Income/Loss:
$17.12B
P/E Ratio:
13.09
EPS:
6.7297
Net Cash Flow:
$14.84B
1W Performance:
-10.77%
1M Performance:
-12.72%
6M Performance:
-21.62%
1Y Performance:
-30.83%
1-Day Range:
$87.20
$88.60
1-Week Range:
$87.20
$100.15
52-Week Range:
$87.20
$134.63
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
88.19 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
|
LLY
Lilly Eli Co
|
879.29 | 827.20B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
86.55 | 386.95B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
153.97 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
192.29 | 341.01B | 56.33B | 4.28B | 15.62B | 2.40 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Generate Investment Management Ltd - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Tobam - MarketBeat
Fairvoy Private Wealth LLC Invests $1.74 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $717.52 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Grows Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Q1 EPS Forecast for Merck & Co., Inc. Increased by Analyst - MarketBeat
RNC Capital Management LLC Acquires 258,910 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ledyard National Bank Has $10.61 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hedeker Wealth LLC Has $5.40 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Silver Oak Securities Incorporated Acquires 3,002 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Robertson Stephens Wealth Management LLC Trims Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Market Whales and Their Recent Bets on MRK Options - Benzinga
Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Buck Wealth Strategies LLC Has $8.90 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Initiates Phase 3 Trial of Zilovertamab Vedotin Antibody-Drug Conjugate to Treat Lymphoma - Marketscreener.com
Merck: launch of a phase 3 study in lymphoma -February 06, 2025 at 08:24 am EST - Marketscreener.com
State of Alaska Department of Revenue Cuts Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
The Merck & Co., Inc. (NYSE:MRK) Annual Results Are Out And Analysts Have Published New Forecasts - Simply Wall St
Long Run Wealth Advisors LLC Has $3.66 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Inman Jager Wealth Management LLC Invests $1.37 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma - Business Wire
Financial Advisory Partners LLC Sells 2,875 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co Inc (MRK) Pharmaceutical Stock: Prospects & Analysis - INDODAX
Merck: Don't Fight The Tape, How Low Can It Go? (NYSE:MRK) - Seeking Alpha
Is Merck & Co. (MRK) the Best Dividend Stock to Buy and Hold? - Insider Monkey
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance - Benzinga
Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $112.00 by Analysts at Bank of America - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $115.00 by Analysts at Citigroup - MarketBeat
Meritage Portfolio Management Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Choreo LLC Increases Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Tectonic Advisors LLC Buys 9,062 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q4 2024 Earnings Call Transcript - MSN
Why Merck & Co. Inc. (MRK) Went Down on Tuesday - Insider Monkey
Hager Investment Management Services LLC Invests $1.52 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Lockheed Martin Investment Management Co. Raises Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Stratos Investment Management LLC - MarketBeat
Paragon Capital Management Inc. Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sargent Investment Group LLC Grows Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Yousif Capital Management LLC Cuts Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc.'s (NYSE:MRK) latest 6.9% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance
1858 Wealth Management LLC Has $912,000 Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Cassia Capital Partners LLC Acquires 3,632 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Avitas Wealth Management LLC - MarketBeat
Merck & Co Inc (MRK) Shares Gap Down to $89.1 on Feb 4 - GuruFocus.com
Sylvest Advisors LLC Takes Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
CENTRAL TRUST Co Sells 14,133 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ... - Yahoo Finance
Symphony Financial Ltd. Co. Boosts Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
New Millennium Group LLC Sells 10,713 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):